Ingeborg Hartz

770 total citations
33 papers, 560 citations indexed

About

Ingeborg Hartz is a scholar working on Psychiatry and Mental health, Clinical Psychology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ingeborg Hartz has authored 33 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 11 papers in Clinical Psychology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ingeborg Hartz's work include Attention Deficit Hyperactivity Disorder (9 papers), Child and Adolescent Psychosocial and Emotional Development (9 papers) and Maternal Mental Health During Pregnancy and Postpartum (5 papers). Ingeborg Hartz is often cited by papers focused on Attention Deficit Hyperactivity Disorder (9 papers), Child and Adolescent Psychosocial and Emotional Development (9 papers) and Maternal Mental Health During Pregnancy and Postpartum (5 papers). Ingeborg Hartz collaborates with scholars based in Norway, Sweden and Denmark. Ingeborg Hartz's co-authors include Svetlana Skurtveit, Marte Handal, Annette Løvheim Kleppang, Anne Elise Eggen, Curt Hagquist, Miranda Thurston, Kari Furu, Inger Njølstad, Aage Tverdal and Bodil Wilde‐Larsson and has published in prestigious journals such as Social Science & Medicine, European Heart Journal and BMC Public Health.

In The Last Decade

Ingeborg Hartz

32 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ingeborg Hartz Norway	15	158	141	119	91	87	33	560
Claire J. Hoogendoorn United States	12	71 0.4×	170 1.2×	146 1.2×	68 0.7×	72 0.8×	36	640
Jean‐Louis Terra France	12	148 0.9×	192 1.4×	112 0.9×	77 0.8×	41 0.5×	27	919
Yasmina Molero Sweden	16	179 1.1×	302 2.1×	95 0.8×	59 0.6×	64 0.7×	37	783
Olivera Bogunovic United States	12	204 1.3×	86 0.6×	114 1.0×	155 1.7×	90 1.0×	23	602
Hristina Petkova United Kingdom	7	200 1.3×	198 1.4×	160 1.3×	72 0.8×	38 0.4×	13	546
Marie Longo Australia	16	100 0.6×	119 0.8×	148 1.2×	85 0.9×	35 0.4×	24	909
Geetha Shivakumar United States	13	202 1.3×	287 2.0×	221 1.9×	82 0.9×	87 1.0×	28	800
Ester Saghafi United States	6	184 1.2×	149 1.1×	131 1.1×	61 0.7×	50 0.6×	8	700
Misty A.W. Hawkins United States	19	121 0.8×	306 2.2×	200 1.7×	81 0.9×	65 0.7×	71	1.0k
David K. Chatkoff United States	8	204 1.3×	147 1.0×	73 0.6×	44 0.5×	100 1.1×	13	766

Countries citing papers authored by Ingeborg Hartz

Since Specialization

Citations

This map shows the geographic impact of Ingeborg Hartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingeborg Hartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingeborg Hartz more than expected).

Fields of papers citing papers by Ingeborg Hartz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingeborg Hartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingeborg Hartz. The network helps show where Ingeborg Hartz may publish in the future.

Co-authorship network of co-authors of Ingeborg Hartz

This figure shows the co-authorship network connecting the top 25 collaborators of Ingeborg Hartz. A scholar is included among the top collaborators of Ingeborg Hartz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingeborg Hartz. Ingeborg Hartz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hartz, Ingeborg, et al.. (2024). Nationwide trends in the use of ADHD medications in the period 2006–2022: a study from the Norwegian prescription database. BMC Psychiatry. 24(1). 767–767. 1 indexed citations

Skurtveit, Svetlana, Ingeborg Hartz, Rikke Wesselhöeft, et al.. (2024). Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study. Journal of Clinical Medicine. 13(4). 1075–1075.

Kleppang, Annette Løvheim, Mário Vianna Vettore, Ingeborg Hartz, Siri Håvås Haugland, & Tonje Holte Stea. (2023). Patterns of unhealthy behaviours during adolescence and subsequent anxiety and depression in adulthood: a prospective register linkage study of the HUNT survey and health registries. International Journal of Behavioral Nutrition and Physical Activity. 20(1). 6–6. 9 indexed citations

Sørensen, Anne Mette Skov, Rikke Wesselhöeft, Jacob Harbo Andersen, et al.. (2022). Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020. European Child & Adolescent Psychiatry. 32(10). 2049–2056. 13 indexed citations

Wesselhöeft, Rikke, Lotte Rasmussen, Peter Bjødstrup Jensen, et al.. (2021). Use of hypnotic drugs among children, adolescents, and young adults in Scandinavia. Acta Psychiatrica Scandinavica. 144(2). 100–112. 24 indexed citations

Furu, Kari, Vidar Hjellvik, Ingeborg Hartz, et al.. (2018). Legemiddelbruk hos barn og unge i Norge 2008–2017. Duo Research Archive (University of Oslo). 3 indexed citations

Nesvåg, Ragnar, Jørgen G. Bramness, Marte Handal, et al.. (2018). The incidence, psychiatric co-morbidity and pharmacological treatment of severe mental disorders in children and adolescents. European Psychiatry. 49. 16–22. 10 indexed citations

Kleppang, Annette Løvheim, Miranda Thurston, Ingeborg Hartz, & Curt Hagquist. (2017). Psychological distress among Norwegian adolescents: Changes between 2001 and 2009 and associations with leisure time physical activity and screen-based sedentary behaviour. Scandinavian Journal of Public Health. 47(2). 166–173. 30 indexed citations

Nesvåg, Ragnar, Ingeborg Hartz, Jørgen G. Bramness, et al.. (2016). Mental disorder diagnoses among children and adolescents who use antipsychotic drugs. European Neuropsychopharmacology. 26(9). 1412–1418. 15 indexed citations

10.

Hartz, Ingeborg, et al.. (2016). Psychotropic drug use among 0–17 year olds during 2004–2014: a nationwide prescription database study. BMC Psychiatry. 16(1). 12–12. 50 indexed citations

11.

Wilde‐Larsson, Bodil, et al.. (2012). Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study. Clinical Epidemiology. 4. 225–225. 27 indexed citations

12.

Skurtveit, Svetlana, et al.. (2012). The association between prescribed opioid use for mothers and children: a record-linkage study. European Journal of Clinical Pharmacology. 69(1). 111–118. 10 indexed citations

13.

Skurtveit, Svetlana, et al.. (2011). Dispensing of prescribed analgesics in Norway among young people with foreign-or Norwegian-born parents. Scandinavian Journal of Pain. 2(1). 36–44. 3 indexed citations

14.

Hartz, Ingeborg, Aage Tverdal, Eivind Å. Skille, & Svetlana Skurtveit. (2010). Disability pension as predictor of later use of benzodiazepines among benzodiazepine users. Social Science & Medicine. 70(6). 921–925. 5 indexed citations

15.

Hartz, Ingeborg, et al.. (2010). The association between smoking and subsequent repeated use of prescribed opioids among adolescents and young adults—a population‐based cohort study. Pharmacoepidemiology and Drug Safety. 20(1). 90–98. 18 indexed citations

16.

Hartz, Ingeborg, Aage Tverdal, & Svetlana Skurtveit. (2010). Social inequalities in use of potentially addictive drugs in Norway – use among disability pensioners. Norsk Epidemiologi. 19(2). 2 indexed citations

17.

Melbye, Hasse, Dag S. Halvorsen, Ingeborg Hartz, et al.. (2007). Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly.. Respiratory Medicine. 101(12). 2541–2549. 28 indexed citations

18.

Hartz, Ingeborg, Inger Njølstad, Kari Furu, Svetlana Skurtveit, & Anne Elise Eggen. (2006). Why do sales of lipid-lowering drugs vary between counties in Norway?. Scandinavian Journal of Primary Health Care. 24(2). 115–121. 3 indexed citations

19.

Hartz, Ingeborg, Inger Njølstad, & Anne Elise Eggen. (2005). Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001. European Heart Journal. 26(24). 2673–2680. 42 indexed citations

20.

Hartz, Ingeborg, et al.. (2004). Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Troms� study 2001. European Journal of Clinical Pharmacology. 60(9). 643–649. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact